News & Perspective

Jan 20, 2012

Jan 20, 2012

Researchers announce pause in controversial H5N1 studies

(CIDRAP News) – Leading influenza researchers from around the world, faced with a relentless controversy over experiments dealing with potentially dangerous H5N1 viruses, today announced a 60-day pause in such research to allow time to discuss its risks, benefits, and oversight.

Sep 09, 2011

Sep 09, 2011

'Contagion' portrays extreme but not impossible scenario

(CIDRAP News) – In the film "Contagion," opening in theaters today, a respiratory virus from Malaysia makes its way from bats to humans, spreading quickly around the world and killing a high proportion of those infected. It's clearly an extreme scenario, but not an impossible one, say experts who have seen the movie.

Feb 23, 2009

Feb 23, 2009

Researchers find antibody that fights H5N1, seasonal flu strains

(CIDRAP News) – In a development that could create new tools to prevent and treat seasonal and pandemic influenza, researchers have identified and tested human monoclonal antibodies (mAbs) that can neutralize influenza A viruses, including lethal H5N1 avian influenza.

Oct 02, 2008

Oct 02, 2008

Study: First flu wave in 1918 was vaccine for some

(CIDRAP News) – In the influenza pandemic of 1918, those who got sick in the first wave of illness were up to 94% less likely to fall ill when the second and much more severe wave struck, according to a new analysis of historical data.

May 28, 2008

May 28, 2008

Some avian flu H7 viruses growing more human-like

(CIDRAP News) – Scientists have found evidence that North American avian influenza viruses of the H7 subtype are becoming more like human flu viruses in their ability to attach to host cells, which suggests they may be improving their capacity to infect humans.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 02, 2007

Nov 02, 2007

THE PANDEMIC VACCINE PUZZLE Part 7: Time for a vaccine 'Manhattan Project'?

Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.

Jul 16, 2007

Jul 16, 2007

Study: Inhibiting cytokine response might not reverse H5N1 infections

(CIDRAP News) – Scientists have hoped that disabling the body's destructive immune-system overreaction to the H5N1 avian influenza virus, known as "cytokine storm," could lead to new lifesaving treatments, but according to a new study, trials testing the strategy didn't protect mice infected with the disease.

Jun 08, 2007

Jun 08, 2007

Human antibodies protect mice from H5N1 avian flu

(CIDRAP News) – Antibodies gleaned from four Vietnamese patients who survived H5N1 avian influenza were used successfully to prevent and treat H5N1 infection in mice, suggesting that the same approach might be useful in humans, according to a recent report by an international team of researchers.

Apr 03, 2007

Apr 03, 2007

Social distancing helped some cities endure 1918 pandemic

(CIDRAP News) – Social control measures such as closing schools and banning public gatherings played a significant role in slowing the advance of the 1918 influenza pandemic in a number of US cities, but their success depended on how soon the measures were deployed and how slowly they were lifted, two teams of researchers reported yesterday.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»